TIMP1_HUMAN - dbPTM
TIMP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TIMP1_HUMAN
UniProt AC P01033
Protein Name Metalloproteinase inhibitor 1
Gene Name TIMP1
Organism Homo sapiens (Human).
Sequence Length 207
Subcellular Localization Secreted .
Protein Description Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 and MMP16. Does not act on MMP14. Also functions as a growth factor that regulates cell differentiation, migration and cell death and activates cellular signaling cascades via CD63 and ITGB1. Plays a role in integrin signaling. Mediates erythropoiesis in vitro; but, unlike IL3, it is species-specific, stimulating the growth and differentiation of only human and murine erythroid progenitors..
Protein Sequence MAPFEPLASGILLLLWLIAPSRACTCVPPHPQTAFCNSDLVIRAKFVGTPEVNQTTLYQRYEIKMTKMYKGFQALGDAADIRFVYTPAMESVCGYFHRSHNRSEEFLIAGKLQDGLLHITTCSFVAPWNSLSLAQRRGFTKTYTVGCEECTVFPCLSIPCKLQSGTHCLWTDQLLQGSEKGFQSRHLACLPREPGLCTWQSLRSQIA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
25PhosphorylationIAPSRACTCVPPHPQ
HCCCCCCCCCCCCCC
18.6226091039
45UbiquitinationSDLVIRAKFVGTPEV
CCEEEEEEECCCCCC
30.6321906983
49PhosphorylationIRAKFVGTPEVNQTT
EEEEECCCCCCCCCC
15.8027174698
53N-linked_GlycosylationFVGTPEVNQTTLYQR
ECCCCCCCCCCCHHE
31.6416263699
53N-linked_GlycosylationFVGTPEVNQTTLYQR
ECCCCCCCCCCCHHE
31.6416263699
55PhosphorylationGTPEVNQTTLYQRYE
CCCCCCCCCCHHEEE
17.3627174698
56PhosphorylationTPEVNQTTLYQRYEI
CCCCCCCCCHHEEEE
17.4427174698
58PhosphorylationEVNQTTLYQRYEIKM
CCCCCCCHHEEEEEE
6.7227174698
58NitrationEVNQTTLYQRYEIKM
CCCCCCCHHEEEEEE
6.72-
61PhosphorylationQTTLYQRYEIKMTKM
CCCCHHEEEEEEHHH
13.3827174698
66PhosphorylationQRYEIKMTKMYKGFQ
HEEEEEEHHHCHHHH
13.9929083192
69PhosphorylationEIKMTKMYKGFQALG
EEEEHHHCHHHHHHH
14.9829083192
70UbiquitinationIKMTKMYKGFQALGD
EEEHHHCHHHHHHHC
50.152190698
101N-linked_GlycosylationGYFHRSHNRSEEFLI
HHHHCCCCCCCEEEE
50.8816740002
141UbiquitinationAQRRGFTKTYTVGCE
HHHCCCCEEEEECCC
36.95-
143NitrationRRGFTKTYTVGCEEC
HCCCCEEEEECCCCC
10.86-
178PhosphorylationTDQLLQGSEKGFQSR
EHHHHCCCCCCCCCC
24.1522427646
180UbiquitinationQLLQGSEKGFQSRHL
HHHCCCCCCCCCCEE
67.72-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
178SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TIMP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TIMP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RECQ5_HUMANRECQL5physical
16169070
ECH1_HUMANECH1physical
16169070
EF1B_HUMANEEF1B2physical
16169070
MMP3_HUMANMMP3physical
9288970
MMP1_HUMANMMP1physical
9063449
ZBT16_HUMANZBTB16physical
17340613
PCSK5_MOUSEPcsk5physical
16135528

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TIMP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach.";
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
Mol. Cell. Proteomics 5:226-233(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53, AND MASS SPECTROMETRY.
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry.";
Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.;
J. Proteome Res. 5:1493-1503(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53 AND ASN-101, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53, AND MASS SPECTROMETRY.

TOP